Search Results - "Calderon, Benôit"

Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial by TAO, Yungan, Sun, Xu-Shan, Pointreau, Yoann, Le Tourneau, Christophe, Sire, Christian, Kaminsky, Marie-Christine, Coutte, Alexandre, Alfonsi, Marc, Calderon, Benôit, Boisselier, Pierre, Martin, Laurent, Miroir, Jessica, Ramee, Jean-Francois, Delord, Jean-Pierre, Clatot, Florian, Rolland, Frederic, Villa, Julie, Magne, Nicolas, Elicin, Olgun, Gherga, Elisabeta, Nguyen, France, Lafond, Cédrik, Bera, Guillaume, Calugaru, Valentin, Geoffrois, Lionnel, Chauffert, Bruno, Damstrup, Lars, Crompton, Philippa, Ennaji, Abdallah, Gollmer, Kathrin, Nauwelaerts, Heidi, Bourhis, Jean

“…We report long-term efficacy and overall survival (OS) results from a randomised, double-blind, phase 2 study (NCT02022098) investigating xevinapant plus…”
Get full text

Stereotactic radiotherapy for brain metastases: predictive factors of radionecrosis by Calderon, Benoît, Vazquez, Léa, Belkacemi, Mohammed, Pourel, Nicolas

“…Stereotactic radiotherapy (SRT) is a highly effective approach and represents the current standard of treatment for patients with limited number of brain…”
Get full text

Prognostic factors for ovarian epithelial cancer in the elderly: a case-control study by Sabatier, Renaud, Calderon, Jr, Benoît, Lambaudie, Eric, Chereau, Elisabeth, Provansal, Magali, Cappiello, Maria-Antonietta, Viens, Patrice, Rousseau, Frederique

“…Ovarian cancer is the leading cause of mortality by gynecologic cancers in Western countries. Many publications have suggested that age may be an independent…”
Get more information

Pembrolizumab Treatment-Induced Liver Toxicity by Calderon, Benoît, Stancu, Alma, Vanel, François-Roger, Vazquez, Léa

“…T cells play a critical role in immune responses against neoplasm. This finding contributed to the immunotherapy development, an effective treatment for many…”
Get full text

The management of bone metastasis by Bonetto, Rémi, Tallet, Agnès, Mélot, Anthony, Calderon, Benoît, Barlesi, Fabrice

“…Bone metastasis are the most common cause of pain related to cancer, reducing patients' quality of life, and sometimes threatening their life-expectancy. Their…”
Get more information

Results of the multicenter phase II FRAIL-IMMUNE trial evaluating the efficacy and safety of durvalumab combined with weekly paclitaxel carboplatin in first-line in patients (pts) with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) not eligible for cisplatin-based therapies by Fayette, Jerome, Cropet, Claire, Gautier, Julien, Toullec, Clemence, Burgy, Mickael, Bruyas, Amandine, Sire, Christian, Lagrange, Aurelie, Clatot, Florian, Calderon, Benoit, Vinches, Marie, Iacob, Mariana, Martin, Laurent, Neidhardt Berard, Eve Marie, Kaminsky, Marie-Christine, Vansteene, Damien, Salas, Sébastien, Champagnac, Anne, Pérol, David, Bourhis, Jean

“…6003 Background: For pts with R/M SCCHN, new standard of care (SoC) has been recently established with pembrolizumab either alone or combined with platin-5FU…”
Get full text

Prise en charge des métastases osseuses by Bonetto, Rémi, Tallet, Agnès, Mélot, Anthony, Calderon, Benoît, Barlesi, Fabrice

“…Les métastases osseuses représentent la cause la plus fréquente de douleur liée au cancer, diminuant la qualité de vie des patients et pouvant mettre en jeu le…”
Get full text

Radiation therapy following targeted therapy in oligometastatic renal cell carcinoma by GRAVIS, GWENAELLE, FAURE, MARJORIE, RYBIKOWSKI, STANISLAS, DERMECHE, SLIMANE, TYRAN, MARGUERITE, CALDERON, BENOIT, THOMASSIN, JEANNE, WALZ, JOCHEN, SALEM, NAJI

“…Up to 40% of patients with renal cell carcinoma (RCC) with initially localized disease eventually develop metastasis following nephrectomy. The current…”
Get full text